Leveraging Oral Solid Dose Technologies for the Development and Manufacturing of Potent Treatments
Summary: The discovery of new treatment modalities for oncology, neurology and rare diseases has seen a shift away from broad spectrum drugs in favor of more targeted, and often more potent drugs. One driver contributing to this growth is the rise of highly selective biological targeting mechanisms, which are capable of more precisely attacking only specific sites of action and can therefore be more potent than non-targeted treatments. However, converting such highly potent drug substances into drug products comes with formulation and process development challenges. With state-of-the-art containment and appropriate delivery technologies, such as oral solid dose technologies, highly potent drug products can be safely developed and manufactured into effective treatments.
Join this panel of industry experts as they delve into the driving forces that have created the recent surge in treatments for oncology and rare disease. Attendees will gain insights into the challenges and opportunities presented in the development and manufacturing of potent treatments. The featured speakers will discuss how the choice of appropriate oral solid dose technologies can help overcome development and manufacturing obstacles. Attendees will discover how industry leaders have utilized oral solid dose technologies through real-world case studies.